i
Investigational drug available directly from CDC for the treatment of free-living ameba infections
-
8/23/13
Series: HAN ; 354
Details:
-
Corporate Authors:
-
Description:August 23, 2013, 11:30 ET (11:30 AM ET)
HANINFO-00354
Summary: CDC now has an expanded access investigational new drug (IND) protocol in effect with the Food and Drug Administration (FDA) to make miltefosine available directly from CDC to
clinicians for treatment of free-living ameba (FLA) infections in the United States.
-
Subject:
-
Series:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +